Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 1996;75:635-638; doi:10.1136/hrt.75.6.635
Copyright © 1996 BMJ Publishing Group Ltd & British Cardiovascular Society

Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks.

S. M. Sopher, F. D. Murgatroyd, A. K. Slade, I. Blankoff, E. Rowland, D. E. Ward, A. J. Camm

St George's Hospital, London.

OBJECTIVE: To investigate the efficacy of internal cardioversion using low energy shocks delivered with a biatrial electrode configuration in chronic atrial fibrillation resistant to transthoracic shocks. METHODS: Low energy internal cardioversion was attempted in 11 patients who had been in atrial fibrillation for 233 (SD 193) days and had failed to cardiovert with transthoracic shocks of 360 J in both apex-base and anterior-posterior positions. Synchronised biphasic shocks of up to 400 V (approximately 6 J) were delivered, usually with intravenous sedation only, between high surface area electrodes in the right atrium and the left atrium (coronary sinus in nine, left pulmonary artery in one, left atrium via patent foramen ovale in one). RESULTS: Sinus rhythm was restored in 8/11 patients. The mean leading edge voltage of successful shocks was 363 (46) V [4.9 (1.2) J]. Higher energy shocks induced transient bradycardia [time to first R wave 1955 (218) ms]. No proarrhythmia or other acute complications were observed. CONCLUSIONS: Low energy internal cardioversion of atrial fibrillation can restore sinus rhythm in patients in whom conventional transthoracic shocks have failed.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Soran, H., Younis, N., Currie, P., Silas, J., Jones, I.R., Gill, G. (2008). Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation. QJM 101: 181-187 [Abstract] [Full Text]  
  • Siaplaouras, S., Jung, J., Buob, A., Heisel, A. (2004). Incidence and management of early recurrent atrial fibrillation (ERAF) after transthoracic electrical cardioversion. Europace 6: 15-20 [Abstract] [Full Text]  
  • Gallagher, M. M., Hennessy, B. J., Edvardsson, N., Hart, C. M., Shannon, M. S., Obel, O. A., Al-Saady, N. M., Camm, A. J. (2002). Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion. J Am Coll Cardiol 40: 926-933 [Abstract] [Full Text]  
  • Biffi, M, Boriani, G, Bartolotti, M, Bacchi Reggiani, L, Zannoli, R, Branzi, A (2002). Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart 87: 443-448 [Abstract] [Full Text]  
  • Andraghetti, A., Scalese, M. (2001). Safety and efficacy of low-energy cardioversion of 500 patients using two different techniques. Europace 3: 4-9 [Abstract]  
  • Gasparini, G., Bonso, A., Themistoclakis, S., Giada, F., Raviele, A. (2001). Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up. Europace 3: 90-95 [Abstract]  
  • Saliba, W., Juratli, N., Chung, M. K., Niebauer, M. J., Erdogan, O., Trohman, R., Wilkoff, B. L., Augostini, R., Mowrey, K. A., Nadzam, G. R., Tchou, P. J. (1999). Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation. J Am Coll Cardiol 34: 2031-2034 [Abstract] [Full Text]  
  • Oral, H., Souza, J. J., Michaud, G. F., Knight, B. P., Goyal, R., Strickberger, S. A., Morady, F. (1999). Facilitating Transthoracic Cardioversion of Atrial Fibrillation with Ibutilide Pretreatment. NEJM 340: 1849-1854 [Abstract] [Full Text]  
  • Boriani, G., Biffi, M., Capucci, A., Bronzetti, G., Ayers, G. M., Zannoli, R., Branzi, A., Magnani, B. (1999). Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. J Am Coll Cardiol 33: 333-341 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.